Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-09

Clinical Trial Update: Steroids Helping Albuterol Responders Exclusively [NA]

View source ↗

Summary

The clinical trial evaluating steroids to enhance albuterol response in bronchiolitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol (albuterol)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bronchiolitis | NA | Status: WITHDRAWN